Lonza Group Ag (OTCMKTS:LZAGY) Sees Large Decrease in Short Interest

Lonza Group Ag (OTCMKTS:LZAGY) was the target of a large decline in short interest during the month of July. As of July 31st, there was short interest totaling 16,610 shares, a decline of 70.7% from the July 15th total of 56,620 shares. Based on an average trading volume of 100,225 shares, the days-to-cover ratio is presently 0.2 days. Approximately 0.0% of the shares of the company are short sold.

Lonza Group Trading Down 1.9%

Lonza Group stock traded down $1.31 during mid-day trading on Friday, hitting $69.10. 19,950 shares of the company’s stock traded hands, compared to its average volume of 75,917. The company has a current ratio of 2.24, a quick ratio of 1.77 and a debt-to-equity ratio of 0.42. The firm has a 50 day simple moving average of $67.55 and a two-hundred day simple moving average of $65.62. Lonza Group has a fifty-two week low of $58.53 and a fifty-two week high of $73.85.

Lonza Group Company Profile

Lonza Group is a Swiss multinational life sciences company that provides products and services to the pharmaceutical, biotech and specialty ingredients markets. Headquartered in Switzerland, the company operates globally with manufacturing and research facilities across Europe, North America and Asia, serving customers involved in drug discovery, development and commercial production. Lonza’s client base ranges from large pharmaceutical firms to emerging biotech companies and manufacturers of consumer health and specialty chemical products.

The company’s core activities center on contract development and manufacturing (CDMO) for small molecules and biologics, including process development, clinical and commercial-scale manufacturing, and fill–finish services.